Bitnile holdings announces additional investment in alzamend from completion of phase 1 first-in-human clinical trial for al001 treatment of dementia related to alzheimer's

Las vegas--(business wire)---- $acad #acimmune--bitnile holdings announces add'l investment in alzamend from completion of phase 1 first-in-human clinical trial for lithium treatment of alzheimer's

ACAD Ratings Summary

ACAD Quant Ranking